We are live on ! Find out more
JNJ icon

Johnson & Johnson

4,151 hedge funds and large institutions have $289B invested in Johnson & Johnson in 2025 Q1 according to their latest regulatory filings, with 253 funds opening new positions, 1,704 increasing their positions, 1,841 reducing their positions, and 148 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more call options, than puts

Call options by funds: $4.67B | Put options by funds: $2.57B

71% more first-time investments, than exits

New positions opened: 253 | Existing positions closed: 148

55% more funds holding in top 10

Funds holding in top 10: 146226 (+80)

12% more capital invested

Capital invested by funds: $257B → $289B (+$31.9B)

1% more funds holding

Funds holding: 4,1084,151 (+43)

0.4% more ownership

Funds ownership: 72.03%72.43% (+0.4%)

7% less repeat investments, than reductions

Existing positions increased: 1,704 | Existing positions reduced: 1,841

Holders
4,151
Holders Change
+43
Holders Change %
+1.05%
% of All Funds
55.62%
Holding in Top 10
226
Holding in Top 10 Change
+80
Holding in Top 10 Change %
+54.79%
% of All Funds
3.03%
New
253
Increased
1,704
Reduced
1,841
Closed
148
Calls
$4.67B
Puts
$2.57B
Net Calls
+$2.09B
Net Calls Change
+$1.56B
Name Holding Trade Value Shares
Change
Change in
Stake
AMG
1701
Asset Management Group
Connecticut
$2.92M +$18K +115 +0.7%
TC
1702
TAGStone Capital
North Carolina
$2.92M -$805K -5,148 -23%
ZF
1703
Zhang Financial
Michigan
$2.92M +$815K +5,210 +42%
OC
1704
Oarsman Capital
Wisconsin
$2.91M +$90K +575 +3%
BSI
1705
Bennett Selby Investments
Maine
$2.91M +$23.2K +148 +0.9%
IRAG
1706
Investment Research & Advisory Group
Georgia
$2.9M +$366K +2,339 +15%
CPRC
1707
Consolidated Portfolio Review Corp
New York
$2.9M +$143K +912 +6%
DCM
1708
Delta Capital Management
New Jersey
$2.89M -$75.9K -485 -3%
GI
1709
GLOBALT Investments
Georgia
$2.88M -$123K -785 -4%
MMG
1710
Monetary Management Group
Missouri
$2.88M -$78.2K -500 -3%
CPC
1711
CFC Planning Company
Indiana
$2.88M +$638K +4,078 +31%
BIA
1712
Bigelow Investment Advisors
Maine
$2.87M -$136K -867 -5%
GIM
1713
Guardian Investment Management
California
$2.87M -$335K -2,140 -11%
SFM
1714
Signet Financial Management
New Jersey
$2.87M -$97.5K -623 -3%
HFBOT
1715
Home Federal Bank of Tennessee
Tennessee
$2.87M -$10.6K -68 -0.4%
AIC
1716
Archer Investment Corporation
Indiana
$2.87M +$166K +1,061 +7%
CPBTD
1717
Central Pacific Bank - Trust Division
Hawaii
$2.86M -$208K -1,328 -7%
ZIG
1718
Zullo Investment Group
Pennsylvania
$2.86M +$64.9K +415 +2%
MWM
1719
Massachusetts Wealth Management
Massachusetts
$2.85M -$70.4K -450 -3%
BB
1720
Burford Brothers
Texas
$2.85M +$1.29M +8,214 +92%
MYIA
1721
Mount Yale Investment Advisors
Colorado
$2.85M -$190K -1,216 -7%
TGAM
1722
TBH Global Asset Management
Tennessee
$2.83M -$291K -1,861 -10%
KA
1723
Klingman & Associates
New York
$2.82M +$314K +2,005 +13%
AWA
1724
Arete Wealth Advisors
Illinois
$2.81M +$2.66K +17 +0.1%
JF
1725
Jump Financial
Illinois
$2.81M -$2.31M -14,762 -47%

JNJ Hedge Fund Activity: Q1 2025 in Review

4,151 of the 7,463 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q1 2025, worth a combined $289B — up 12% from $257B a quarter earlier.

Buyers outnumbered sellers: 253 funds opened new JNJ positions and 148 closed out — a net gain of 105 holders — while 1,704 added to existing stakes and 1,841 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $2.39B. The largest seller was T. Rowe Price Associates, cutting an estimated $967M.

  • 4,151 institutional investors held Johnson & Johnson (JNJ) as of Q1 2025, up from 4,108 in Q4 2024.
  • Funds reported $289B of Johnson & Johnson stock for Q1 2025, up 12% quarter-over-quarter.
  • 253 funds opened new Johnson & Johnson positions in Q1 2025 and 148 closed out, a net change of +105 holders.
  • The largest Johnson & Johnson buyer in Q1 2025 was JP Morgan Chase, an estimated $2.39B added.
  • The largest Johnson & Johnson seller in Q1 2025 was T. Rowe Price Associates, an estimated $967M sold.

Based on aggregated 13F filings for Q1 2025.